#aaith ,,congress #b;d ,session ,s4 #ahch ,,an ,,act ,to amend the ,public ,health ,service ,act to authorize the ,secretary of ,health and ,human ,services to carry out a program of research1 training1 and investigation related to ,down syndrome1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,de,ondra ,dixon ,,include ,project ,act of #bjbf4 #b4 ,de,ondra ,dixon ,,include ,project ,part ,b of title ,,iv of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhd et seq47 is amended by adding at the end the following3 #dji,k4 ,down syndrome research 7a7 ,in general ,the ,director of ,,nih shall carry out a program of research1 training1 and investigation related to ,down syndrome to be known as the ,i,nvestigation of ,co-occurring conditions across the ,lifespan to ,understand ,down syndrom,e ,project or the ,,include ,project4 7b7 ,program elements ,the program under subsection 7a7 shall include-- 7#a7 high-risk1 high-reward research on the effects of trisomy #ba on human development and health2 7#b7 promoting research for participants with ,down syndrome across the lifespan1 including cohort studies to facilitate improved understanding of ,down syndrome and co-occurring conditions and development of new interventions2 7#c7 expanding the number of clinical trials that are inclusive of1 or expressly for1 participants with ,down syndrome1 including novel biomedical and pharmacological interventions and other therapies designed to promote or enhance activities of daily living2 7#d7 research on the biological mechanisms in individuals with ,down syndrome pertaining to structural1 functional1 and behavioral anomalies and dysfunction as well as stunted growth2 7#e7 supporting research to improve diagnosis and treatment of conditions co-occurring with ,down syndrome1 including the identification of biomarkers related to risk factors1 diagnosis1 and clinical research and therapeutics2 7#f7 research on the causes of increased prevalence1 and concurrent treatment1 of co-occurring conditions1 such as ,alzheimer's disease and related dementias and autoimmunity1 in individuals with ,down syndrome2 and 7#g7 research1 training1 and investigation on improving the quality of life of individuals with ,down syndrome and their families4 7c7 ,coordination2 prioritizing nonduplicative research ,the ,director of ,,nih shall ensure that-- 7#a7 the programs and activities of the institutes and centers of the ,national ,institutes of ,health relating to ,down syndrome and co-occurring conditions are coordinated1 including through the ,office of the ,director of ,,nih and priority-setting reviews conducted pursuant to section #djb7;b77#c72 and 7#b7 such institutes and centers1 prioritize1 as appropriate1 ,down syndrome research that does not duplicate existing research activities of the ,national ,institutes of ,health4 7d7 ,consultation with stakeholders ,in carrying out activities under this section1 the ,director of ,,nih shall1 as appropriate and to the maximum extent feasible1 consult with relevant stakeholders1 including patient advocates1 to ensure that such activities take into consideration the needs of individuals with ,down syndrome4 7e7 ,biennial reports to ,congress 7#a7 ,in general ,the ,director of ,,nih shall submit1 on a biennial basis1 to the ,committee on ,energy and ,commerce and the ,subcommittee on ,labor1 ,health and ,human ,services1 ,education1 and ,related ,agencies of the ,committee on ,appropriations of the ,house of ,representatives and the ,committee on ,health1 ,education1 ,labor1 and ,pensions and the ,subcommittee on ,labor1 ,health and ,human ,services1 ,education1 and ,related ,agencies of the ,committee on ,appropriations of the ,senate1 a report that catalogs the research conducted or supported under this section4 7#b7 ,contents ,each report under paragraph 7#a7 shall include-- 7,a7 identification of the institute or center involved2 7,b7 a statement of whether the research is or was being carried out directly by such institute or center or by multiple institutes and centers2 and 7,c7 identification of any resulting real-world evidence that is or may be used for clinical research and medical care for patients with ,down syndrome4 4 ,passed the ,senate ,august #f1 #bjbf4,secretary